
New treatments for deadly snake bites, and a fusion company that wants to get in the medical isotopes game
Science Magazine Podcast
Exploring the use of CRISPR and heparin to treat snake venom toxicity
The chapter delves into using CRISPR to study the effects of snake venoms on cells and identifying which genes aid or worsen the venom's toxic effects. It discusses how heparin, a blood clotting drug, can be repurposed to block snake venom toxins by acting as a decoy, showing promising results in reducing tissue damage in mice and potentially in humans. The research also explores screening systems for targeting neurotoxic substances in venoms to develop new treatments against a variety of venomous animals.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.